It can be argued that other inflammatory markers, such as C-Reactive Protein (CRP), would be preferable alternatives [39] given the widely validated prognostic effect of the Glasgow Prognostic Score (CRP and albumin) across numerous cancer populations; however, this is not routinely collected at the time of clinical staging in our practice. This evidence concerns the gene ALB and cancer.